The role of noninvasive hemodynamic monitoring in the evaluation and treatment of hypertension

Therapeutic Advances in Cardiovascular Disease

Volumn 1, Issue 2, 2007, Pages 113-118

  Ferrario, Carlos M ^a   Smith, Ronald D ^a   Basile, Jan ^b   Bestermann, William ^c   Frohlich, Edward ^d   Houston, Mark ^e   Lackland, Daniel T ^b   Wise, Daniel L ^f  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Holston Medical Group   (United States)

^d OCHSNER MEDICAL CENTER   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Presbyterian Center for Preventative Cardiology Charlotte   (United States)

Author keywords

Hemodynamics; Hypertension; Impedance Cardiography; Noninvasive; Risk Factors

Indexed keywords

AMLODIPINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; PERINDOPRIL; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

AORTA PRESSURE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; HEMODYNAMIC MONITORING; HUMAN; HYPERTENSION; IMPEDANCE CARDIOGRAPHY; MEAN ARTERIAL PRESSURE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; RADIAL ARTERY; REVIEW; WAVEFORM; HEART LEFT VENTRICLE FUNCTION; PATHOPHYSIOLOGY; RISK FACTOR;

CARDIOGRAPHY, IMPEDANCE; HUMANS; HYPERTENSION; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 59049092081     PISSN: 17539447     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753944707086095     Document Type: Review

References (47)

1. Abdelhammed, A.I.et al. (2005)Noninvasive hemodynamic profiles in hypertensive subjects. Am J Hypertens 18:51S–59S.
2. Alfie, J.et al. (1995)Relationship between systemic hemodynamics and ambulatory blood pressure level are sex dependent. Hypertension 26:1195–1199.
3. Bestermann, W.et al. (2005)Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome. Am J Med Sci 329:292–305.
4. Bhalla, V.et al. (2005)Diagnostic ability of B-type natriuretic peptide and impedance cardiography: testing to identify left ventricular dysfunction in hypertensive patients. Am J Hypertens 18:73S–81S.
5. Cherry, D.K. and Woodwell, D.A. (2002)National Ambulatory Medical Care Survey: 2000 summary. Adv Data 1–32.
6. Chirinos, J.A. (2006)Impedance Cardiography identifies subclinical systolic dysfunction associated with obesity: a population-based study. Chest Meeting Abstracts 130:196S-c–197S-c.
7. Cohn, J.N.et al. (2005)Arterial elasticity as part of a comprehensive assessment of cardiovascular risk and drug treatment. Hypertension 46:217–220.
8. Elliott, W.J. and Black, H.R. (2007)Prehypertension. Nat Clin Pract Cardiovasc Med 4:538–548.
9. Ferrario, C.M. and Smith, R.D. (2006)Cost-effectiveness of impedance cardiography testing in uncontrolled hypertension. Am Heart Hosp J 4:279–289.
10. Fields, L.E.et al. (2004)The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 44:398–404.
11. Freis, E.D. (2001)Studies in hemodynamics and hypertension. Hypertension 38:1–5.
12. Galarza, C.R.et al. (1997)Diastolic pressure underestimates age-related hemodynamic impairment. Hypertension 30:809–816.
13. Garg, J.P.et al. (2005)Resistant hypertension revisited: a comparison of two university-based cohorts. Am J Hypertens 18:619–626.
14. Giles, T.D.et al. (2005)Expanding the definition and classification of hypertension. J Clin Hypertens (Greenwich) 7:505–512.
15. Hansen, M.L.et al. (2007)Underdiagnosis of hypertension in children and adolescents. J Am Med Assoc 298:874–879.
16. Houston, M.C.et al. (2005)Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States. Am J Med Sci 329:276–291.
17. Izzo, Jr, J.L. (2005)Pulse contour analysis and augmentation index: it's time to move beyond cuff blood pressure measurement. Am J Hypertens 18:1S–2S.
18. Julius, S.et al. (2006)Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 354:1685–1697.
19. Lewington, S.et al. (2002) Age-specific relevance of usual blood pressure to vascular mortality:
20. a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903–1913.
21. London, G.M. and Cohn, J.N. (2002)Prognostic application of arterial stiffness: task forces. Am J Hypertens 15:754–758.
22. Mancia, G.et al. (2007 a)2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 25:1751–1762.
23. Mancia, G.et al. (2007 b)2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the european society of hypertension (ESH) and of the european society of cardiology (ESC). J Hypertens 25:1105–1187.
24. Muiesan, M.L.et al. (1996)Cardiac and vascular structural changes. Prevalence and relation to ambulatory blood pressure in a middle-aged general population in northern Italy: the Vobarno Study. Hypertension 27:1046–1052.
25. National Cholesterol Education Program.(2002 ) Third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. In:Bethesda, MD: National Institute of Health, p. NIH Pub. No. 02-5215.
26. Nichols, W.W. (2005)Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms. Am J Hypertens 18:3S–10S.
27. Nurnberger, J.et al. (2002)Augmentation index is associated with cardiovascular risk. J Hypertens 20:2407–2414.
28. O'Rourke, M.F. and Seward, J.B. (2006)Central arterial pressure and arterial pressure pulse: new views entering the second century after Korotkov. Mayo Clin Proc 81:1057–1068.
29. Okin, P.M.et al. (2004)Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. J Am Med Assoc 292:2343–2349.
30. Okonofua, E.C.et al. (2006)Therapeutic inertia is an impediment to achieving the healthy people 2010 blood pressure control goals. Hypertension 47:345–351.
31. Phillips, L.S.et al. (2001)Clinical inertia. Ann Intern Med 135:825–834.
32. Resnick, L.M. and Lester, M.H. (2002)Differential effects of antihypertensive drug therapy on arterial compliance. Am J Hypertens 15:1096–1100.
33. Rossi, R.et al. (2004)Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women. J Am Coll Cardiol 44:1636–1640.
34. Sheps, S.G. and Frohlich, E.D. (1997)Limited echocardiography for hypertensive left ventricular hypertrophy. Hypertension 29:560–563.
35. Smith, R.D., Levy, P. and Ferrario, C.M. (2006)Value of noninvasive hemodynamics to achieve blood pressure control in hypertensive subjects. Hypertension 47:771–777.
36. Taler, S.J.et al. (2002)Resistant hypertension: comparing hemodynamic management to specialist care. Hypertension 39:982–988.
37. Treister, N.et al. (2005)Reproducibility of impedance cardiography parameters in outpatients with clinically stable coronary artery disease. Am J Hypertens 18:44S–50S.
38. Turnbull, F. (2003)Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 362:1527–1535.
39. van de Water, J.M.et al. (2003)Impedance cardiography: the next vital sign technology? Chest 123:2028–2033.
40. Ventura, H.O.et al. (2005)Hypertension as a hemodynamic disease: the role of impedance cardiography in diagnostic, prognostic, and therapeutic decision making. Am J Hypertens 18:26S–43S.
41. Wang, T.J. and Vasan, R.S. (2005)Epidemiology of uncontrolled hypertension in the United States. Circulation 112:1651–1662.
42. Wang, Y. and Wang, Q.J. (2004)The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med 164:2126–2134.
43. Williams, B. (2005)Recent hypertension trials: implications and controversies. J Am Coll Cardiol 45:813–827.
44. Williams, B.et al. (2006)Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 113:1213–1225.
45. Wilson, P.W.et al. (1998)Prediction of coronary heart disease using risk factor categories. Circulation 97:1837–1847.
46. Yu, Y.et al. (2002)Correlation of functional and structural alterations of the coronary arterioles during development of type II diabetes mellitus in rats. Cardiovasc Res 56:303–311.
47. Zanchetti, A. and Waeber, B. (2006)Hypertension: which aspects of hypertension should we impact on and how? J Hypertens (Suppl 24): S2– S5.